What is Axogen Inc (AXGN) stock price today?

Axogen Inc (AXGN) currently trades at $43.20 per share. The stock has a market capitalization of $2.22B and a P/E ratio of —x.

Is AXGN stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Axogen Inc has a Smart Value Score of 30/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 3/9 and Altman Z-Score is —.

What is Axogen Inc's revenue and earnings?

Axogen Inc has trailing twelve-month (TTM) revenue of $238.10M with profit margins of -13.20%. Earnings per share (EPS) is $-0.64.

Is Axogen Inc financially healthy?

Axogen Inc's Piotroski F-Score is 3/9 (weak financial health). The Altman Z-Score of — places it in the —.

AXGN

Axogen Inc

NASDAQ: AXGN · HEALTHCARE · MEDICAL DEVICES

$43.20

+3.42% today

Updated 2026-04-30

Market cap

$2.22B

P/E ratio

—

P/S ratio

9.33x

EPS (TTM)

$-0.64

Dividend yield

—

52W range

$9 – $46

Volume

1.1M

Market cap

$2.22B

P/E ratio

—

P/S ratio

9.33x

EPS (TTM)

$-0.64

Dividend yield

—

52W range

$9 – $46

Volume

1.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

6.7

Growth

5.3

Quality

C+

2.0

Profitability

4.0

Valuation

3/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$48.89

+13.17%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

2 Strong Buy7 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Free cash flow $1.79M — positive

+ Revenue growth 26.60% QoQ

Risks

- Piotroski 3/9 — weak financial health

- Altman Z 0.00 — distress zone

- Thin margins at -13.20%

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$138.58M	$159.01M	$187.34M	$225.21M	$238.10M
Net income	$-28.95M	$-21.72M	$-9.96M	$-15.70M	$-13.16M
EPS	—	—	—	—	$-0.64
Free cash flow	$-37.32M	$-20.63M	$11000.00	$-2.93M	$1.79M
Profit margin	-20.89%	-13.66%	-5.32%	-6.97%	-13.20%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
AXGN	$2.22B	30	6.7	2.0	4.0	5.3	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Axogen Inc trades at $43.20. Our Smart Value Score of 30/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. TTM revenue stands at $238.10M. with profit margins at -13.20%.

Frequently asked questions

What is Axogen Inc's stock price?

Axogen Inc (AXGN) trades at $43.20.

Is Axogen Inc overvalued?

Smart Value Score 30/100 (Grade F, Strong Sell).

What is the price target of Axogen Inc (AXGN)?

The analyst target price is $48.89, representing +13.2% upside from the current price of $43.20.

What is Axogen Inc's revenue?

TTM revenue is $238.10M.

Piotroski F-Score?

3/9 — weak financial health.

Company info

SectorHEALTHCARE

IndustryMEDICAL DEVICES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio9.33x

ROE-18.00%

Beta0.98

50D MA$33.51

200D MA$25.51

Shares out0.05B

Float0.05B

Short ratio—

Avg volume1.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

AXGN vs LLY →AXGN vs JNJ →AXGN vs ABBV →Stock screener →